MCQOPTIONS
Saved Bookmarks
| 1. |
In Aug 2020, the Drug Controller General of India’s office has approved whose application for phase II and III clinical trials of the University of Oxford’s COVID-19 vaccine candidate Covishield? |
| A. | Panacea Biotec |
| B. | Shantha Biotechnics |
| C. | Biocon |
| D. | Serum Institute of India |
| E. | Sun Pharma |
| Answer» E. Sun Pharma | |